No products
View larger | Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $8.50 | Total: $42.50 |
| 1 | 10 | $7.20 | Total: $72.00 |
| 1 | 25 | $6.10 | Total: $152.50 |
| 1 | 50 | $5.20 | Total: $260.00 |
| 1 | 100 | $4.50 | Total: $450.00 |
| Molecular Formula | C13H11N3O4 |
| Molecular Weight | 273.24 |
| CAS Numbers | 19171-19-8 |
| Storage Condition | 0°C (short term), -20°C (long term), desiccated |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| Synonym | CC4047; CC 4047; CC-4047; Pomalidomide. Brand name: Pomalyst. |
| IUPAC/Chemical Name | 4-amino-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione |
| InChl Key | UVSMNLNDYGZFPF-UHFFFAOYSA-N |
| InChl Code | InChI=1S/C13H11N3O4/c14-7-3-1-2-6-10(7)13(20)16(12(6)19)8-4-5-9(17)15-11(8)18/h1-3,8H,4-5,14H2,(H,15,17,18) |
| SMILES Code | O=C1N(C(CC2)C(NC2=O)=O)C(C3=C1C=CC=C3N)=O |
| References | 1) Elkinson S, McCormack PL. Pomalidomide: First Global Approval. Drugs. 2013 Apr 10. [Epub ahead of print] PubMed PMID: 23572409. 2) Traynor K. Pomalidomide approved for multiple myeloma. Am J Health Syst Pharm. 2013 Mar 15;70(6):474. doi: 10.2146/news130020. PubMed PMID: 23456394. |